Cite
HARVARD Citation
Mei, Z. et al. (2023). Lenvatinib enhances antitumor immunity by promoting the infiltration of TCF1+ CD8+ T cells in HCC via blocking VEGFR2. Cancer science. 114 (4), pp. 1284-1296. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mei, Z. et al. (2023). Lenvatinib enhances antitumor immunity by promoting the infiltration of TCF1+ CD8+ T cells in HCC via blocking VEGFR2. Cancer science. 114 (4), pp. 1284-1296. [Online].